Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/24/18
End: 07/17/18
Due: 07/17/19
Phase: N/A
Priority: Normal
Start: 11/30/18
End: 12/23/19
Due: 12/23/20
Phase: N/A
Priority: Normal
Start: 10/30/20
End: 01/15/21
Due: 01/15/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD | NCT03404466 | Zhejiang Huahai Pharmaceutical Co., Ltd. | user2@example.com | None | 2018-02-24 | 2018-07-17 | 2019-07-17 | - | - | 2025-07-14 |
| Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets | NCT03739632 | Zhejiang Huahai Pharmaceutical Co., Ltd. | user2@example.com | None | 2018-11-30 | 2019-12-23 | 2020-12-23 | - | - | 2025-07-14 |
| Tolerability and Pharmacokinetics of Hypidone Hydrochloride in Healthy Subjects | NCT04598607 | Zhejiang Huahai Pharmaceutical Co., Ltd. | user2@example.com | None | 2020-10-30 | 2021-01-15 | 2022-01-15 | - | - | 2025-07-14 |